论文信息 - Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol - 字舞流文

Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol

S. Severi | S. Ricci | R. Berardi | D. Santini | F. Foca | S. Tamberi | F. Gelsomino | T. Ibrahim | F. Bergamo | G. Di Meglio | S. Leo | S. Pusceddu | C. Liverani | Alberto Bongiovanni | I. Lolli | F. Pucci